Bioinformatics analysis revealed that many different types of tumor tissues expressed LAIR1 at higher levels than those in their corresponding normal tissues, particularly in acute myeloid leukemia, esophageal cancer, brain tumor, renal clear cell carcinoma and thymoma (Fig. S1A). Here, LAIR1 is linked to brain neoplasm.